1. Inicio
  2. Publicaciones
  3. Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.

Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Vivas D
  • Roldán I
  • Marín F
  • Roldán V
  • Tello-Montoliu A
  • Ruiz-Nodar JM
  • Gómez-Doblas JJ
  • Martín A
  • Llau JV
  • Ramos-Gallo MJ
  • Muñoz R
  • Arcelus JI
  • Leyva F
  • Alberca F
  • Oliva R
  • Gómez AM
  • Montero C
  • Arikan F
  • Ley L
  • Santos-Bueso E
  • Figuero E
  • Bujaldón A
  • Urbano J
  • Otero R
  • Hermida JF
  • Egocheaga I
  • Llisterri JL
  • Lobos JM
  • Serrano A
  • Madridano O
  • Ferreiro JL

Grupos

Abstract

During the last few years, the number of patients receiving anticoagulant and antiplatelet therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can be expected to need some kind of surgery or intervention during their lifetime that may require treatment discontinuation. The decision to withdraw antithrombotic therapy depends on the patient's thrombotic risk versus hemorrhagic risk. Assessment of both factors will show the precise management of anticoagulant and antiplatelet therapy in these scenarios. The aim of this consensus document, coordinated by the Cardiovascular Thrombosis Working Group of the Spanish Society of Cardiology, and endorsed by most of the Spanish scientific societies of clinical specialities that may play a role in the patient-health care process during the perioperative or periprocedural period, is to recommend some simple and practical guidelines with a view to homogenizing daily clinical practice.

Datos de la publicación

ISSN/ISSNe:
1885-5857, 1885-5857

REVISTA ESPANOLA DE CARDIOLOGIA  Elsevier Doyma

Tipo:
Article
Páginas:
553-564
PubMed:
29887180
Factor de Impacto:
0,352 SCImago ℠
Cuartil:
Q3 SCImago ℠

Citas Recibidas en Web of Science: 68

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Antiagregación, Anticoagulación, Anticoagulation, Antiplatelet, Antithrombotic, Antitrombótico, Cirugía, Surgery

Proyectos y Estudios Clínicos

ENSAYO DE FASE III, ALEATORIZADO, DOBLE CIEGO, MULTICÉNTRICO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE OCTAPLEX, UN CONCENTRADO DE COMPLEJO DE PROTROMBINA DE CUATRO FACTORES (CCP-4F), EN COMPARACIÓN CON EL CCP-4F BERIPLEX® P/N (KCENTRA), PARA LA REVERSIÓ N DE LA ANTICOAGULACIÓN INDUCIDA POR ANTAGONISTAS DE LA VITAMINA K EN PACIENTES QUE REQUIEREN UNA INTERVENCIÓN QUIRÚRGICA DE URGENCIA Y QUE TIENEN UN RIESGO SIGNIFICATIVO DE HEMORRAGIA.

Investigador Principal: MARÍA AZUCENA PAJARES MONCHO

LEX-209 . 2017

Compartir